The UK government has secured 150,000 doses of Bavarian Nordic’s mpox vaccine to target a new variant of the virus originating from the Democratic Republic of Congo. Although the clade I mpox strain has not been reported in the UK, concerns arise as it spreads to neighboring countries, prompting preparations for a potential outbreak. The vaccine distribution will be conducted in phases, prioritizing individuals based on guidelines to effectively address the emerging threat.
Full Article




